Home > Boards > US Listed > Biotechs > Opko Health Inc (OPK)

Lol

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
notagain1 Member Profile
 
Followed By 25
Posts 2,908
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2020 7:54:56 AM
FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients GlobeNewswire Inc. - 6/1/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/29/2020 7:21:43 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/27/2020 8:04:25 AM
OPKO Health to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire Inc. - 5/27/2020 8:00:10 AM
MagnaCare and BioReference Laboratories Bring COVID-19 Antibody Testing to New York Labor Groups PR Newswire (US) - 5/18/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 4:07:34 PM
OPKO Health's BioReference Laboratories Launches COVID-19 Employer Solution PR Newswire (US) - 5/13/2020 4:05:00 PM
OPKO Health's BioReference Laboratories and Westchester Medical Center Health Network Enter Into Strategic Laboratory Collabo... PR Newswire (US) - 5/13/2020 8:30:00 AM
OPKO Health's BioReference Laboratories Launches COVID-19 Antibody Screening for New York City Residents PR Newswire (US) - 5/8/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/8/2020 7:46:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2020 5:20:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2020 4:12:25 PM
OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results GlobeNewswire Inc. - 5/6/2020 4:05:10 PM
OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020 GlobeNewswire Inc. - 4/30/2020 4:05:10 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/29/2020 4:06:54 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/29/2020 4:04:31 PM
OPKO Health's BioReference Laboratories in Partnership with New York State Initiates Testing for COVID-19 Antibodies PR Newswire (US) - 4/29/2020 1:35:00 PM
Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020 GlobeNewswire Inc. - 4/22/2020 8:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/20/2020 8:06:50 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/17/2020 8:03:11 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/16/2020 8:21:47 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/8/2020 8:03:02 AM
OPKO Health's BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with ... PR Newswire (US) - 4/6/2020 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/6/2020 8:18:36 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist